Barriers to accessing DMTs Barrier present in country of interest? World Bank category Lower middle income WHO region European Global results
% of countries reporting each barrier
Lack of awareness of DMTs amongst healthcare professionals No 30% 20% 27%
Healthcare professionals not readily available No 39% 12% 30%
Equipment or tests to monitor treatments not available No 57% 12% 27%
Too expensive for the government, healthcare/insurance provider No 74% 27% 49%
People with MS do not take DMTs due to costs, side-effects or preference for other treatments or lifestyle measures No 52% 24% 39%
DMTs only available in some areas of the country or certain hospitals No 48% 5% 27%
DMTs frequently go out of stock or supply is irregular No 26% 0% 8%
DMTs not supplied to the country Yes 35% 5% 18%
Complete range of DMTs not available Yes 52% 17% 30%
Bureaucracy, inefficiency or complexity in health system No 22% 22% 25%
Other No 4% 5% 5%
Not sure No 0% 0% 2%
No major barriers No 4% 46% 26%

Please note - full data set provides additional detail on the barriers relating to healthcare professionals, equipment/tests and people with MS

What is the Atlas of MS?

The Atlas of MS is the most comprehensive worldwide study of the epidemiology of MS and the global availability and accessibility of resources for people with MS.

Explore the latest MS data

Access the latest Atlas of MS reports, infographics, slides and datasets to support research, advocacy and policy development. Planning an analysis or publication? Contact the Atlas team at [email protected] for guidance on methodology, data interpretation and related work.

Powerful tool for change

The information in the Atlas of MS can be a powerful advocacy tool, shining a spotlight on MS and raising awareness of the lack of adequate resources available to diagnose, inform, treat, rehabilitate and support people with MS worldwide.

With thanks to…

Worldwide collaboration

The Atlas of MS relies on data supplied by MS organisations from around the world. We are most grateful to the country coordinators and their colleagues for taking the time and effort to gather the information and data.

See contributor list

The Atlas of MS is one of the strongest examples of what the global MS movement can achieve through collaboration. By bringing together evidence from countries around the world, it helps inform policy, strengthen advocacy and guide future investment in research and healthcare. The Atlas also highlights the need for continued investment in surveillance, registries and data systems to strengthen our understanding of the true burden of MS. Better data lead to better decisions and, ultimately, better outcomes for people affected by MS worldwide.

Professor Mario Alberto Battaglia
Chair, MS International Federation (MSIF) and President of the Italian MS Society (Associazione Italiana Sclerosi Multipla [AISM])